Nascent Biotech Achieves Two Key Milestones in Development of its Novel Brain Cancer Treatment

… /Phase 2 human trials on Brain Cancers, with more than adequate amounts … Orphan Drug Designation for Gliomas (brain cancer).  "This will give us …